User: Guest  Login
More Searchfields
Simple search
Title:

Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.

Document type:
Article; Journal Article
Author(s):
Innes, Hamish; Buch, Stephan; Hutchinson, Sharon; Guha, Indra Neil; Morling, Joanne R; Barnes, Eleanor; Irving, Will; Forrest, Ewan; Pedergnana, Vincent; Goldberg, David; Aspinall, Esther; Barclay, Stephan; Hayes, Peter C; Dillon, John; Nischalke, Hans Dieter; Lutz, Philipp; Spengler, Ulrich; Fischer, Janett; Berg, Thomas; Brosch, Mario; Eyer, Florian; Datz, Christian; Mueller, Sebastian; Peccerella, Teresa; Deltenre, Pierre; Marot, Astrid; Soyka, Michael; McQuillin, Andrew; Morgan, Marsha Y; Ha...     »
Abstract:
BACKGROUND AND AIMS: Little is known about genetic factors that affect development of alcohol-related cirrhosis. We performed a genome-wide association study (GWAS) of samples from the United Kingdom Biobank (UKB) to identify polymorphisms associated with risk of alcohol-related liver disease. METHODS: We performed a GWAS of 35,839 participants in the UKB with high intake of alcohol against markers of hepatic fibrosis (FIB-4, APRI, and Forns index scores) and hepatocellular injury (levels of aminotransferases). Loci identified in the discovery analysis were tested for their association with alcohol-related cirrhosis in 3 separate European cohorts (phase 1 validation cohort; n=2545). Variants associated with alcohol-related cirrhosis in the validation at a false discovery rate of less than 20% were then directly genotyped in 2 additional European validation cohorts (phase 2 validation, n=2068). RESULTS: In the GWAS of the discovery cohort, we identified 50 independent risk loci with genome-wide significance (P < 5 × 10-8). Nine of these loci were significantly associated with alcohol-related cirrhosis in the phase 1 validation cohort; 6 of these 9 loci were significantly associated with alcohol-related cirrhosis in phase 2 validation cohort, at a false discovery rate below 5%. The loci included variants in the mitochondrial amidoxime reducing component 1 gene (MARC1) and the heterogeneous nuclear ribonucleoprotein U like 1 gene (HNRNPUL1). After we adjusted for age, sex, body mass index, and type-2 diabetes in the phase 2 validation cohort, the minor A allele of MARC1:rs2642438 was associated with reduced risk of alcohol-related cirrhosis (adjusted odds ratio, 0.76; P=.0027); conversely, the minor C allele of HNRNPUL1:rs15052 was associated with an increased risk of alcohol-related cirrhosis (adjusted odds ratio, 1.30; P=.020). CONCLUSIONS: In a GWAS of samples from the UKB, we identified and validated (in 5 European cohorts) single-nucleotide polymorphisms that affect risk of alcohol-related cirrhosis in opposite directions: the minor A allele in MARC1:rs2642438 decreases risk, whereas the minor C allele in HNRNPUL1:rs15052 increases risk.
Journal title abbreviation:
Gastroenterology
Year:
2020
Journal volume:
159
Journal issue:
4
Pages contribution:
1276-1289.e7
Fulltext / DOI:
doi:10.1053/j.gastro.2020.06.014
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/32561361
Print-ISSN:
0016-5085
TUM Institution:
2. Medizinische Klinik Toxikologische Abteilung (alt) (Prof. Zilker)
 BibTeX